Winton Group LTD Supernus Pharmaceuticals, Inc. Transaction History

Winton Group LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Jul 21, 2021	SELL	$24.15 - $31.45 $375,991 - $489,645	-15,569 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$17.7 - $25.81 $114,483 - $166,939	-6,468 Reduced 29.35%	15,569 $392,000
Q3 2020 Oct 30, 2020	SELL	$20.2 - $25.05 $2.61 Million - $3.23 Million	-129,129 Reduced 85.42%	22,037 $459,000
Q2 2020 Aug 05, 2020	SELL	$17.09 - $24.89 $3.62 Million - $5.28 Million	-212,034 Reduced 58.38%	151,166 $3.59 Million
Q1 2020 May 11, 2020	BUY	$14.45 - $24.69 $301,268 - $514,761	20,849 Added 6.09%	363,200 $6.53 Million
Q4 2019 Feb 13, 2020	SELL	$19.93 - $29.13 $3.61 Million - $5.27 Million	-181,074 Reduced 34.59%	342,351 $8.12 Million
Q3 2019 Nov 08, 2019	BUY	$25.47 - $33.37 $3.81 Million - $4.99 Million	149,559 Added 40.0%	523,425 $14.4 Million
Q2 2019 Jul 08, 2019	BUY	$29.96 - $38.87 $2.11 Million - $2.74 Million	70,566 Added 23.27%	373,866 $12.4 Million
Q1 2019 May 13, 2019	BUY	$32.77 - $41.99 $541,196 - $693,464	16,515 Added 5.76%	303,300 $10.6 Million
Q4 2018 Feb 05, 2019	BUY	$30.84 - $49.51 $8.11 Million - $13 Million	263,097 Added 1110.68%	286,785 $9.53 Million
Q3 2018 Nov 02, 2018	BUY	$42.7 - $56.55 $628,415 - $832,246	14,717 Added 164.05%	23,688 $0
Q2 2018 Aug 20, 2018	SELL	$44.1 - $59.85 $283,298 - $384,476	-6,424 Reduced 41.73%	8,971 $0
Q1 2018 May 21, 2018	BUY	$37.15 - $46.9 $571,924 - $722,025	15,395 New	15,395 $0

303

60.6M

22.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.75B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.